Video
How CTCL Treatment Strategies Have Changed, Advanced in Recent Years
Lauren C. Pinter-Brown, MD, FACP, of UCI Health and Chao Family Comprehensive Cancer Center, addresses how the treatment of advanced cutaneous T cell lymphoma has changed in recent years and whether there have been any advancements of note.
Pharmacy Times interviewed Lauren C. Pinter-Brown, MD, FACP, professor in the Department of Dermatology and the Department of Medicine in the Division of Hematology and Oncology at UCI Health and Chao Family Comprehensive Cancer Center, on her recent presentation at the Society of Hematologic Oncology Annual Meeting 2021 conference on the treatment of advanced cutaneous T cell lymphoma (CTCL) in 2021.
During this discussion, Pinter-Brown addresses how the treatment of CTCL has changed in recent years and whether there have been any advancements of note.
